History Of Cadiology

Home » Neurology

« Go Back

Stem Cell Therapy News Now Available on Twitter

The XCell-Center announces the official launch of its stem cell therapy news campaign on Twitter.com to meet the demand of prospective and treated patients who wish to receive real-time updates on treatment success stories, newly available treatments and other newsworthy events.

North American Seminars Inc. has been Recognized by the California Board of Physical Therapy as an Approval Agency to Approve Providers for Continuing Competency Courses

The California Board of Physical Therapy requires that physical therapy continuing education course in California meet the requirements set forth by the board in order to be accepted for physical therapy license renewal. Effective January 11, 2010 North American Seminars, Inc. has been recognized by the California Board of Physical Therapy as an Approval Agency to Approve Providers for Continuing Competency Courses

Major Imaging Initiative to Shed Light on Little Known Brain Disease

UCSF scientists have received a $10 million grant from the National Institutes of Health to embark on a major neuroimaging study of a degenerative brain disease that is at least as common as Alzheimer’s disease in people under age 6

New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting

A new, in-home training device with virtual reality cues improving gait and balance in patients with Parkinson's disease was presented by lead researcher Dr. Alberto Espay at the American Acadamy of Neurology annual meeting.

Veterinary Neurology Clinic Makes Capital Investment

Veterinary neurologist Dr. Anne Chauvet invests $90,000 in new diagnostand surgical equipment for her Veterinary Neuro Services clinic in Sarasota, Fla.

Oral MS Drug Fampridine is Trifecta of Firsts for People with MS, Says National MS Society

FDA approves fampridine SR, now called Ampyra, to improve walking for people with all types of multiple sclerosis. Ampyra is the first symptom management drug developed specifically to treat MS, the first oral therapy approved for MS and the first new FDA approved since 2004.

Migraine Research Foundation Appoints New Board Member

The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to raising funds for migraine research, today announced the appointment of Arnold M. Karp to its Board of Directors.

Brain Abnormalities in Parkinson's Patients Develop Before Symptoms Occur, According to Feinstein Scientists

Scientists who have identified brain networks damaged in Parkinson’s disease have new evidence that these systems become abnormal a few years before symptoms appear. And what’s more, parts of the network appear to respond in a last ditch attempt to rescue the brain.

Free Audio-Conference Call for ALS Patients on Best ALS Treatments to Live Longer, Easier

The American Academy of Neurology and The ALS Association is offering a free audio-conference call at 5 p.m. ET, Thursday, on February 11, 2010 for people with ALS and their caregivers regarding the Academy’s new guidelines on the most effective treatments for ALS.

UCSF Neuroscience Building to Drive Advances Against Brain Diseases

UCSF is set to construct a major neuroscience building on its Mission Bay campus. The building will bring under one roof several of the world’s leading clinical and basic research programs seeking cures for intractable neurological disorders.

Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Next

Page 21 of 60